Sun.Jun 16, 2024

article thumbnail

Inside Anthony Fauci’s ‘On Call’: 9 health and science takeaways from the memoir of America’s most famous doctor

STAT

Anthony Fauci spent 40 years in the top echelons of government. It was no accident. To read the forthcoming memoir by the country’s former top infectious disease expert, “On Call: A Doctor’s Journey in Public Service,” a copy of which was obtained by STAT, is to get a sense of his finesse while advising seven presidents. He strove, he writes, to speak with complete candor and stay out of politics, while remaining strategic in pushing for policies he considered vital t

363
363
article thumbnail

BCGP Exam Study Tips – I Passed! (Again)

Med Ed 101

I recently took the Board Certified Geriatric Pharmacist (BCGP) exam in the spring of 2024 and continue to work in geriatrics. I’m happy to report this was the third time I’ve taken and passed the exam (and recertification exam). I’ve maintained my BCGP certification (formerly CGP) since 2011. I can safely say that I feel […] The post BCGP Exam Study Tips – I Passed!

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ambitious federal study failed to curb opioid deaths, NIH announces

STAT

In 2019, amid an ever-worsening drug crisis, the federal government launched a research study with an ambitious goal: to lower opioid overdoses in participating communities by 40% using evidence-based interventions like distributing naloxone and providing access to addiction medications. But communities that implemented the public health strategies did not see a statistically significant reduction in opioid overdose deaths, according to data published Sunday in the New England Journal of Medicin

360
360
article thumbnail

FDA asks COVID vaccine makers to target KP.2 strain

Express Pharma

The U.S. health regulator recently changed its strain recommendation for the 2024-25 COVID-19 vaccines, as it asked manufacturers to update the new shots to target the KP.2 variant, if feasible, instead of the JN.1 lineage it sought to target earlier. The Food and Drug Administration’s change in recommendation, comes even as Moderna (MRNA.O) and Novavax (NVAX.O) — the makers of two of the three COVID vaccines, submitted their applications to the agency for updating the fall 2024 season sho

Vaccines 105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: I cried tears of loss and rage at the World Hepatitis Summit

STAT

At this year’s World Hepatitis Summit in Lisbon, Portugal, the World Hepatitis Alliance presented me with an award that recognized my leadership as the organization’s president and my advocacy efforts to “improve the lives of people living with viral hepatitis.” As the citation was read aloud, tears started to flow — not tears of joy and pride but of loss and rage.

306
306
article thumbnail

J&J’s nipocalimab raises hope for Sjogren’s patients

pharmaphorum

J&J’s ‘Swiss army knife’ for autoimmune diseases, FcRn inhibitor nipocalimab, has shown efficacy in Sjogren’s disease

116
116

More Trending

article thumbnail

AZ’s Calquence extends disease-free survival in MCL

pharmaphorum

AstraZeneca’s Calquence improved progression-free survival in previously untreated mantle cell lymphoma in the ECHO trial

99
article thumbnail

New patent for Msd Merck drug RECARBRIO

Drug Patent Watch

Annual Drug Patent Expirations for RECARBRIO Recarbrio is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

59
article thumbnail

Episode 931: Non-dextrose purge solution for patients with an Impella that require a PET scan

Pharmacy Joe

In this episode, I’ll discuss an alternative to a dextrose-based purge solution for patients with an Impella ventricular assist device that also need a PET scan. Episode 931: Non-dextrose purge solution for patients with an Impella that require a PET scan Subscribe on iTunes , Android , or Stitcher Positron emission tomography (PET) scanning uses a tracer such as fluoro-deoxyglucose which gets picked up by cells in place of regular glucose for metabolism.

article thumbnail

New patent for Blueprint Medicines drug GAVRETO

Drug Patent Watch

Annual Drug Patent Expirations for GAVRETO Gavreto is a drug marketed by Blueprint Medicines and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

59
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

EHA 2024: Roche’s Columvi competes in BiTE battle with positive results in DLBCL

Pharmaceutical Technology

Based on the latest STARGLO trial results, there is potential to extend Columvi into earlier lines of therapy for diffuse large B-cell lymphoma (DLBCL).

52
article thumbnail

New patent for Novartis drug PLUVICTO

Drug Patent Watch

Annual Drug Patent Expirations for PLUVICTO Pluvicto is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

59
article thumbnail

Growing Use of Herbal Medicine in Cancer Patients Highlights Risks, Communication Gaps

Pharmacy Times

As patients take more proactive roles in their health, they may feel too intimidated to discuss herbal medicinal use with their providers or may be unaware of potential interactions with their drug therapies.

article thumbnail

New patent for Neurocrine drug INGREZZA SPRINKLE

Drug Patent Watch

Annual Drug Patent Expirations for INGREZZA+SPRINKLE Ingrezza Sprinkle is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier.

59
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Thinking, Fast and Slow

RX Note

Introduction "Thinking, Fast and Slow" Summary

52
article thumbnail

Tablet dosed drug patent expirations by year

Drug Patent Watch

This chart shows the patent expirations for tablet dosed drugs over the next decade. The term of drug patents varies.

59